The way we do normal chores is not the only area that has been impacted by the pandemic. Clinical trials run by CROs like Veristat have also been forced to take a different turn from the ways patients are recruited to the monitoring process of the trials. According to reports, over 1,000 trials were put on hold since the onset of the pandemic and others were delayed. The delays were even impacting the trial process and due to the many hindrances that added to the already imposed restrictions to curb the virus.
However, for a Clinical Research Organization to successfully complete their trials, they’ll need to consider working with technology vendors and other parties to bring a revolution in clinical trials. For one, clinical trials have greatly adopted remote monitoring instead of onsite monitoring. The use of technology has now made the entire process easier, efficient, time-saving, and cost-effective. Secondly, the involved parties have adopted the shift towards decentralized clinical trials. This has introduced more innovative technologies that make remote collaboration, data capture, and collection, and patient recruitment and retention even easier.
Why Decentralized Clinical Trials are Gaining Popularity
Technology Puts The Patient First
Patients and participants are at the heart of any clinical trial. Their health and safety always come first. With decentralized or virtual clinical trials, researchers have merged with pharmaceuticals to provide a safe and tech-savvy environment for the patients. This offers an environment that aims at protecting and meeting patients’ needs. What’s more, technology can attract and reach a large participant capacity and make their management and retention even better resulting in reduced drop-out rates. These are some of the biggest challenges that face clinical trials, but with technology, they are easily overcome. Decentralized trails can also be completed within a shorter timeline and at a lower cost.
Beyond Clinical Trials
Decentralized clinical trials help make medical research possible even during the pandemic as everything is done online and uphold the health requirements of social distancing. As technology continues to evolve research trials will continue to change thus making tasks such as the transmission of research results instant with little to no effort from the patients. This will help observe the fundamentals and protocols that revolve around data integrity in clinical trials. However, as much as decentralization with new tech tools is making clinical trials easier and effective, it’s adding some bits of complexity in the whole process. This requires that all the stakeholders commit time and resources to learn how DCTs can be flexible and implemented effectively.
Stakeholders In Clinical Trials
Since the ground for DCTs has not been fully established, stakeholders have to focus on a specific market. There is also the need to evaluate where the line is drawn between decentralized trials and traditional trials if the real benefits of virtual trials are to be realized.
With technology, a whole new world is being created for clinical research. It enables research and CROs to overcome the barriers and challenges posed by the pandemic and mark a new phase and future for research trials with better and efficient outcomes.